US Officially Confirms Europeans With Mixed COVID-19 Vaccines Will Be Eligible to Enter From November 8

The US Centers for Disease Control and Prevention (CDC) has confirmed that European citizens who have been vaccinated with two different doses of the COVID-19 vaccines will be eligible for full vaccination and therefore eligible to enter US soil from November 8.

On Friday evening, after announcing the lifting of the US ban on vaccinated travelers on November 8, a CDC spokesperson confirmed that all travelers had been vaccinated with vaccines approved by the US Food and Drug Administration (FDA) or the World Health Organization. (WHO) will be eligible to enter the United States from the same date.

She also confirmed that those vaccinated with mixed vaccines, which are widely practiced across the European Union countries, will also be recognized as fully immune to the virus.

“While the CDC has not recommended mixing types of the vaccine in a primary series, we recognize that this is increasingly common in other countries, so it should be accepted for interpretation of vaccine records,” the spokeswoman said.

Currently, the only vaccines authorized for use against COVID-19 are Moderna, Pfizer and Janssen. On the other hand, the World Health Organization has approved Pfizer/BioNTech, AstraZeneca (including Covishield), Janssen, Moderna, Sinopharm and Sinovac.

In the European Union, but also in other countries such as Canada, many have been vaccinated with the first AstraZeneca vaccine and the second dose of Pfizer, after the first was found to cause blood clots in some young people.

The question of whether commingled vaccines would be accepted for travel to the United States has been widely debated among travelers and officials since the United States warned it would lift entry bans for those vaccinated in early November.

Just yesterday, prior to the CDC’s confirmation, US Congressman Brian Higgins representing parts of Erie and Niagara counties, sent a letter to the CDC director in this regard.

“Nearly four million Canadians, equivalent to ten percent of their fully vaccinated population, have received mixed doses of available COVID-19 mRNA vaccines — including the AstraZeneca vaccine. Currently, the AstraZeneca vaccine does not appear on the CDC’s list of approved and authorized vaccines. The CDC recommends not mixing doses of COVID-19 mRNA vaccines.”

Following its message, the CDC confirmed that “individuals with any combination of two doses of a two-dose series of approved/authorized COVID-19 or WHO emergency use listed by the Food and Drug Administration are considered fully immune.”

The decision was welcomed by many, particularly by Europeans, many of whom were vaccinated with the first injection of AstraZeneca and the second dose of Pfizer, including here German Chancellor Angela Merkel.

Until the end of September, EU citizens vaccinated with mixed doses faced the same problem when traveling to the UK, where the latter did not recognize mixed-dose vaccination as a complete immunization against COVID-19. However, on September 22, the UK Department of Transport and the Department of Health and Social Care announced that a combination of two different types of vaccine would be accepted as valid proof of vaccination when traveling to the UK.

Schengen Visa

Schengen Countries

Schengen Agreement

Schengen News

Source: schengenvisainfo.com

Enable Notifications    OK No